REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr Theiss D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dr Theiss D.O.O. Beograd Profile Updated: October 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Dr Theiss D.O.O. Beograd is a company based in Serbia, with its head office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was first established on 2011. 28 (2023) employees currently work for Dr Theiss D.O.O. Beograd. From the latest financial highlights, Dr Theiss D.O.O. Beograd reported a net sales revenue increase of 6.8% in 2023. During that time, Dr Theiss D.O.O. Beograd’s total assets grew by 2.84%. In, 2023, the company’s net profit margin increased by 1.06%.

Headquarters
Mihajla Bandura 14
Belgrade; Belgrade;

Contact Details: Purchase the Dr Theiss D.O.O. Beograd report to view the information.

Website: http://CUBE_PROFILES_YU

Basic Information
Total Employees:
Purchase the Dr Theiss D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Dr Theiss D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Dr Theiss D.O.O. Beograd report to view the information.
Incorporation Date:
2011
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Dr Theiss D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
6.8%
Total operating revenue
5.75%
Operating profit (EBIT)
44.92%
EBITDA
40.28%
Net Profit (Loss) for the Period
31.17%
Total assets
2.84%
Total equity
25.35%
Operating Profit Margin (ROS)
1.88%
Net Profit Margin
1.06%
Return on Equity (ROE)
0.89%
Debt to Equity Ratio
-0.64%
Quick Ratio
0.63%
Cash Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?